ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Novel Antiviral Drugs Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-23R1710
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Novel Antiviral Drugs Market Insights Forecast to 2028
BUY CHAPTERS

Global Novel Antiviral Drugs Market Research Report 2025

Code: QYRE-Auto-23R1710
Report
June 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Johnson & Johnson
Merck
Novartis
Dr. Reddy's
Gilead Sciences
Aurobindo Pharma
Cipla Ltd
GlaxoSmithKline
Roche Holding AG
GlaxoSmithKline PLC
Bristol–Myers Squibb

Novel Antiviral Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Novel Antiviral Drugs Market

Novel Antiviral Drugs Market

The global market for Novel Antiviral Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The mechanism of action of antiviral drugs is mainly to inhibit the entry of viral particles into host cells and to inhibit the early stages of viral replication. There is also an inhibitor of DNA polymerase, which is mainly due to its ability to inhibit viral coding. At present, new antiviral drugs are actively seeking host factors, both in the initial stage of viral infection and in the later stages of nuclear transport of viral RNP complexes, to produce new drugs with new modes of action without drug resistance.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Novel Antiviral Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Novel Antiviral Drugs.
The Novel Antiviral Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Novel Antiviral Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Novel Antiviral Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Novel Antiviral Drugs Market Report

Report Metric Details
Report Name Novel Antiviral Drugs Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche Holding AG, GlaxoSmithKline, Bristol-Myers Squibb, AbbVie, Johnson & Johnson, Merck & Co, Novartis, Dr Reddy’s, Gilead Sciences, Aurobindo Pharma, Cipla
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Novel Antiviral Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Novel Antiviral Drugs Market report?

Ans: The main players in the Novel Antiviral Drugs Market are Roche Holding AG, GlaxoSmithKline, Bristol-Myers Squibb, AbbVie, Johnson & Johnson, Merck & Co, Novartis, Dr Reddy’s, Gilead Sciences, Aurobindo Pharma, Cipla

What are the Application segmentation covered in the Novel Antiviral Drugs Market report?

Ans: The Applications covered in the Novel Antiviral Drugs Market report are Hepatitis Therapeutics, HIV/AIDS Therapeutics, Herpes Therapeutics, Influenza Therapeutics, Other

What are the Type segmentation covered in the Novel Antiviral Drugs Market report?

Ans: The Types covered in the Novel Antiviral Drugs Market report are Reverse Transcriptase Inhibitors, Protease Inhibitors, Fusion Inhibitors, Immune System Modulators, Other

Recommended Reports

Antiviral Drug Markets

Virus Diagnostics & Vaccines

Specialized Viral Treatments

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Novel Antiviral Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Reverse Transcriptase Inhibitors
1.2.3 Protease Inhibitors
1.2.4 Fusion Inhibitors
1.2.5 Immune System Modulators
1.2.6 Other
1.3 Market by Application
1.3.1 Global Novel Antiviral Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hepatitis Therapeutics
1.3.3 HIV/AIDS Therapeutics
1.3.4 Herpes Therapeutics
1.3.5 Influenza Therapeutics
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Novel Antiviral Drugs Market Perspective (2020-2031)
2.2 Global Novel Antiviral Drugs Growth Trends by Region
2.2.1 Global Novel Antiviral Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Novel Antiviral Drugs Historic Market Size by Region (2020-2025)
2.2.3 Novel Antiviral Drugs Forecasted Market Size by Region (2026-2031)
2.3 Novel Antiviral Drugs Market Dynamics
2.3.1 Novel Antiviral Drugs Industry Trends
2.3.2 Novel Antiviral Drugs Market Drivers
2.3.3 Novel Antiviral Drugs Market Challenges
2.3.4 Novel Antiviral Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Novel Antiviral Drugs Players by Revenue
3.1.1 Global Top Novel Antiviral Drugs Players by Revenue (2020-2025)
3.1.2 Global Novel Antiviral Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Novel Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Novel Antiviral Drugs Revenue
3.4 Global Novel Antiviral Drugs Market Concentration Ratio
3.4.1 Global Novel Antiviral Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Novel Antiviral Drugs Revenue in 2024
3.5 Global Key Players of Novel Antiviral Drugs Head office and Area Served
3.6 Global Key Players of Novel Antiviral Drugs, Product and Application
3.7 Global Key Players of Novel Antiviral Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Novel Antiviral Drugs Breakdown Data by Type
4.1 Global Novel Antiviral Drugs Historic Market Size by Type (2020-2025)
4.2 Global Novel Antiviral Drugs Forecasted Market Size by Type (2026-2031)
5 Novel Antiviral Drugs Breakdown Data by Application
5.1 Global Novel Antiviral Drugs Historic Market Size by Application (2020-2025)
5.2 Global Novel Antiviral Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Novel Antiviral Drugs Market Size (2020-2031)
6.2 North America Novel Antiviral Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Novel Antiviral Drugs Market Size by Country (2020-2025)
6.4 North America Novel Antiviral Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Novel Antiviral Drugs Market Size (2020-2031)
7.2 Europe Novel Antiviral Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Novel Antiviral Drugs Market Size by Country (2020-2025)
7.4 Europe Novel Antiviral Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Novel Antiviral Drugs Market Size (2020-2031)
8.2 Asia-Pacific Novel Antiviral Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Novel Antiviral Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Novel Antiviral Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Novel Antiviral Drugs Market Size (2020-2031)
9.2 Latin America Novel Antiviral Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Novel Antiviral Drugs Market Size by Country (2020-2025)
9.4 Latin America Novel Antiviral Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Novel Antiviral Drugs Market Size (2020-2031)
10.2 Middle East & Africa Novel Antiviral Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Novel Antiviral Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Novel Antiviral Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Holding AG
11.1.1 Roche Holding AG Company Details
11.1.2 Roche Holding AG Business Overview
11.1.3 Roche Holding AG Novel Antiviral Drugs Introduction
11.1.4 Roche Holding AG Revenue in Novel Antiviral Drugs Business (2020-2025)
11.1.5 Roche Holding AG Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Novel Antiviral Drugs Introduction
11.2.4 GlaxoSmithKline Revenue in Novel Antiviral Drugs Business (2020-2025)
11.2.5 GlaxoSmithKline Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Novel Antiviral Drugs Introduction
11.3.4 Bristol-Myers Squibb Revenue in Novel Antiviral Drugs Business (2020-2025)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Details
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Novel Antiviral Drugs Introduction
11.4.4 AbbVie Revenue in Novel Antiviral Drugs Business (2020-2025)
11.4.5 AbbVie Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Novel Antiviral Drugs Introduction
11.5.4 Johnson & Johnson Revenue in Novel Antiviral Drugs Business (2020-2025)
11.5.5 Johnson & Johnson Recent Development
11.6 Merck & Co
11.6.1 Merck & Co Company Details
11.6.2 Merck & Co Business Overview
11.6.3 Merck & Co Novel Antiviral Drugs Introduction
11.6.4 Merck & Co Revenue in Novel Antiviral Drugs Business (2020-2025)
11.6.5 Merck & Co Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Novel Antiviral Drugs Introduction
11.7.4 Novartis Revenue in Novel Antiviral Drugs Business (2020-2025)
11.7.5 Novartis Recent Development
11.8 Dr Reddy’s
11.8.1 Dr Reddy’s Company Details
11.8.2 Dr Reddy’s Business Overview
11.8.3 Dr Reddy’s Novel Antiviral Drugs Introduction
11.8.4 Dr Reddy’s Revenue in Novel Antiviral Drugs Business (2020-2025)
11.8.5 Dr Reddy’s Recent Development
11.9 Gilead Sciences
11.9.1 Gilead Sciences Company Details
11.9.2 Gilead Sciences Business Overview
11.9.3 Gilead Sciences Novel Antiviral Drugs Introduction
11.9.4 Gilead Sciences Revenue in Novel Antiviral Drugs Business (2020-2025)
11.9.5 Gilead Sciences Recent Development
11.10 Aurobindo Pharma
11.10.1 Aurobindo Pharma Company Details
11.10.2 Aurobindo Pharma Business Overview
11.10.3 Aurobindo Pharma Novel Antiviral Drugs Introduction
11.10.4 Aurobindo Pharma Revenue in Novel Antiviral Drugs Business (2020-2025)
11.10.5 Aurobindo Pharma Recent Development
11.11 Cipla
11.11.1 Cipla Company Details
11.11.2 Cipla Business Overview
11.11.3 Cipla Novel Antiviral Drugs Introduction
11.11.4 Cipla Revenue in Novel Antiviral Drugs Business (2020-2025)
11.11.5 Cipla Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
AbbVie
Johnson & Johnson
Merck
Novartis
Dr. Reddy's
Gilead Sciences
Aurobindo Pharma
Cipla Ltd
GlaxoSmithKline
Roche Holding AG
GlaxoSmithKline PLC
Bristol–Myers Squibb
List of Tables
 Table 1. Global Novel Antiviral Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Reverse Transcriptase Inhibitors
 Table 3. Key Players of Protease Inhibitors
 Table 4. Key Players of Fusion Inhibitors
 Table 5. Key Players of Immune System Modulators
 Table 6. Key Players of Other
 Table 7. Global Novel Antiviral Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Novel Antiviral Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Novel Antiviral Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Novel Antiviral Drugs Market Share by Region (2020-2025)
 Table 11. Global Novel Antiviral Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Novel Antiviral Drugs Market Share by Region (2026-2031)
 Table 13. Novel Antiviral Drugs Market Trends
 Table 14. Novel Antiviral Drugs Market Drivers
 Table 15. Novel Antiviral Drugs Market Challenges
 Table 16. Novel Antiviral Drugs Market Restraints
 Table 17. Global Novel Antiviral Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Novel Antiviral Drugs Market Share by Players (2020-2025)
 Table 19. Global Top Novel Antiviral Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Antiviral Drugs as of 2024)
 Table 20. Ranking of Global Top Novel Antiviral Drugs Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Novel Antiviral Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Novel Antiviral Drugs, Headquarters and Area Served
 Table 23. Global Key Players of Novel Antiviral Drugs, Product and Application
 Table 24. Global Key Players of Novel Antiviral Drugs, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Novel Antiviral Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Novel Antiviral Drugs Revenue Market Share by Type (2020-2025)
 Table 28. Global Novel Antiviral Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Novel Antiviral Drugs Revenue Market Share by Type (2026-2031)
 Table 30. Global Novel Antiviral Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Novel Antiviral Drugs Revenue Market Share by Application (2020-2025)
 Table 32. Global Novel Antiviral Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Novel Antiviral Drugs Revenue Market Share by Application (2026-2031)
 Table 34. North America Novel Antiviral Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Novel Antiviral Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Novel Antiviral Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Novel Antiviral Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Novel Antiviral Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Novel Antiviral Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Novel Antiviral Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Novel Antiviral Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Novel Antiviral Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Novel Antiviral Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Novel Antiviral Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Novel Antiviral Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Novel Antiviral Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Novel Antiviral Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Novel Antiviral Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Roche Holding AG Company Details
 Table 50. Roche Holding AG Business Overview
 Table 51. Roche Holding AG Novel Antiviral Drugs Product
 Table 52. Roche Holding AG Revenue in Novel Antiviral Drugs Business (2020-2025) & (US$ Million)
 Table 53. Roche Holding AG Recent Development
 Table 54. GlaxoSmithKline Company Details
 Table 55. GlaxoSmithKline Business Overview
 Table 56. GlaxoSmithKline Novel Antiviral Drugs Product
 Table 57. GlaxoSmithKline Revenue in Novel Antiviral Drugs Business (2020-2025) & (US$ Million)
 Table 58. GlaxoSmithKline Recent Development
 Table 59. Bristol-Myers Squibb Company Details
 Table 60. Bristol-Myers Squibb Business Overview
 Table 61. Bristol-Myers Squibb Novel Antiviral Drugs Product
 Table 62. Bristol-Myers Squibb Revenue in Novel Antiviral Drugs Business (2020-2025) & (US$ Million)
 Table 63. Bristol-Myers Squibb Recent Development
 Table 64. AbbVie Company Details
 Table 65. AbbVie Business Overview
 Table 66. AbbVie Novel Antiviral Drugs Product
 Table 67. AbbVie Revenue in Novel Antiviral Drugs Business (2020-2025) & (US$ Million)
 Table 68. AbbVie Recent Development
 Table 69. Johnson & Johnson Company Details
 Table 70. Johnson & Johnson Business Overview
 Table 71. Johnson & Johnson Novel Antiviral Drugs Product
 Table 72. Johnson & Johnson Revenue in Novel Antiviral Drugs Business (2020-2025) & (US$ Million)
 Table 73. Johnson & Johnson Recent Development
 Table 74. Merck & Co Company Details
 Table 75. Merck & Co Business Overview
 Table 76. Merck & Co Novel Antiviral Drugs Product
 Table 77. Merck & Co Revenue in Novel Antiviral Drugs Business (2020-2025) & (US$ Million)
 Table 78. Merck & Co Recent Development
 Table 79. Novartis Company Details
 Table 80. Novartis Business Overview
 Table 81. Novartis Novel Antiviral Drugs Product
 Table 82. Novartis Revenue in Novel Antiviral Drugs Business (2020-2025) & (US$ Million)
 Table 83. Novartis Recent Development
 Table 84. Dr Reddy’s Company Details
 Table 85. Dr Reddy’s Business Overview
 Table 86. Dr Reddy’s Novel Antiviral Drugs Product
 Table 87. Dr Reddy’s Revenue in Novel Antiviral Drugs Business (2020-2025) & (US$ Million)
 Table 88. Dr Reddy’s Recent Development
 Table 89. Gilead Sciences Company Details
 Table 90. Gilead Sciences Business Overview
 Table 91. Gilead Sciences Novel Antiviral Drugs Product
 Table 92. Gilead Sciences Revenue in Novel Antiviral Drugs Business (2020-2025) & (US$ Million)
 Table 93. Gilead Sciences Recent Development
 Table 94. Aurobindo Pharma Company Details
 Table 95. Aurobindo Pharma Business Overview
 Table 96. Aurobindo Pharma Novel Antiviral Drugs Product
 Table 97. Aurobindo Pharma Revenue in Novel Antiviral Drugs Business (2020-2025) & (US$ Million)
 Table 98. Aurobindo Pharma Recent Development
 Table 99. Cipla Company Details
 Table 100. Cipla Business Overview
 Table 101. Cipla Novel Antiviral Drugs Product
 Table 102. Cipla Revenue in Novel Antiviral Drugs Business (2020-2025) & (US$ Million)
 Table 103. Cipla Recent Development
 Table 104. Research Programs/Design for This Report
 Table 105. Key Data Information from Secondary Sources
 Table 106. Key Data Information from Primary Sources
 Table 107. Authors List of This Report


List of Figures
 Figure 1. Novel Antiviral Drugs Picture
 Figure 2. Global Novel Antiviral Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Novel Antiviral Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Reverse Transcriptase Inhibitors Features
 Figure 5. Protease Inhibitors Features
 Figure 6. Fusion Inhibitors Features
 Figure 7. Immune System Modulators Features
 Figure 8. Other Features
 Figure 9. Global Novel Antiviral Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Novel Antiviral Drugs Market Share by Application: 2024 VS 2031
 Figure 11. Hepatitis Therapeutics Case Studies
 Figure 12. HIV/AIDS Therapeutics Case Studies
 Figure 13. Herpes Therapeutics Case Studies
 Figure 14. Influenza Therapeutics Case Studies
 Figure 15. Other Case Studies
 Figure 16. Novel Antiviral Drugs Report Years Considered
 Figure 17. Global Novel Antiviral Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Novel Antiviral Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Novel Antiviral Drugs Market Share by Region: 2024 VS 2031
 Figure 20. Global Novel Antiviral Drugs Market Share by Players in 2024
 Figure 21. Global Top Novel Antiviral Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Antiviral Drugs as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Novel Antiviral Drugs Revenue in 2024
 Figure 23. North America Novel Antiviral Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Novel Antiviral Drugs Market Share by Country (2020-2031)
 Figure 25. United States Novel Antiviral Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Novel Antiviral Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Novel Antiviral Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Novel Antiviral Drugs Market Share by Country (2020-2031)
 Figure 29. Germany Novel Antiviral Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Novel Antiviral Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Novel Antiviral Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Novel Antiviral Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Novel Antiviral Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Novel Antiviral Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Novel Antiviral Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Novel Antiviral Drugs Market Share by Region (2020-2031)
 Figure 37. China Novel Antiviral Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Novel Antiviral Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Novel Antiviral Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Novel Antiviral Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Novel Antiviral Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Novel Antiviral Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Novel Antiviral Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Novel Antiviral Drugs Market Share by Country (2020-2031)
 Figure 45. Mexico Novel Antiviral Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Novel Antiviral Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Novel Antiviral Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Novel Antiviral Drugs Market Share by Country (2020-2031)
 Figure 49. Turkey Novel Antiviral Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Novel Antiviral Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Novel Antiviral Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Roche Holding AG Revenue Growth Rate in Novel Antiviral Drugs Business (2020-2025)
 Figure 53. GlaxoSmithKline Revenue Growth Rate in Novel Antiviral Drugs Business (2020-2025)
 Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Novel Antiviral Drugs Business (2020-2025)
 Figure 55. AbbVie Revenue Growth Rate in Novel Antiviral Drugs Business (2020-2025)
 Figure 56. Johnson & Johnson Revenue Growth Rate in Novel Antiviral Drugs Business (2020-2025)
 Figure 57. Merck & Co Revenue Growth Rate in Novel Antiviral Drugs Business (2020-2025)
 Figure 58. Novartis Revenue Growth Rate in Novel Antiviral Drugs Business (2020-2025)
 Figure 59. Dr Reddy’s Revenue Growth Rate in Novel Antiviral Drugs Business (2020-2025)
 Figure 60. Gilead Sciences Revenue Growth Rate in Novel Antiviral Drugs Business (2020-2025)
 Figure 61. Aurobindo Pharma Revenue Growth Rate in Novel Antiviral Drugs Business (2020-2025)
 Figure 62. Cipla Revenue Growth Rate in Novel Antiviral Drugs Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Influenza Flu Antiviral Drugs Market Insights Forecast to 2030
Antiviral Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antiviral Drug Resistance Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antiviral Microbial Drugs Market Research Report 2024
Antiviral Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Direct acting Antiviral Drugs Market
Influenza Antiviral Drugs Market
Antivirals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antiretroviral Agent Market Research Report 2024
Anti Hepatitis Virus Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Respiratory Antiviral Treatment Market Research Report 2024
Global Antiviral Agents EyeDrops Market Insights Forecast to 2030
Global Anti Retroviral Drugs Market Research Report 2024
Hepatic Antiviral Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cold Sore Antiviral Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti infectious Disease Drugs Market Research Report 2025
Respiratory Antivirals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Antiviral Medicine Market Research Report 2025
Global Infectious Disease Drugs Market Insights Forecast to 2030
Global Anti herpesvirus Agent Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions